Antipsychotic drug helps nausea of chemo - USA Today

A commonly used schizophrenia drug, Zyprexa, reduced the number of patients suffering from chemotherapy-related nausea and vomiting by more than half in a study of 80 patients presented before the annual meeting of the American Society of ...

ASCO: For chemo's nausea, olanzapine beats metoclopramide - medicalxpress.com

(HealthDay) -- For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine (Zyprexa) is significantly better than treatment with metoclopramide, according ...

Antipsychotic medication relieves chemo-related nausea - USA Today

A commonly used schizophrenia drug, Zyprexa, reduced the number of patients suffering from chemotherapy-related nausea and vomiting by more than half, according to a study of 80 patients presented in advance of the annual meeting of the American ...

Dr Reddy’s: margins under pressure - Livemint.com

Sales of the company’s generic version of Eli Lily’s Zyprexa amounted to only $2 million, far lower than street estimates of $45 million - $50 million. The generic product was launched in the December quarter and did relatively well initially ...

Lilly's GLP-1 Agonist Delivers - Analyst Blog - Town Hall

The biggest near-term challenge for Eli Lilly will be to replace the revenues that will be lost to generic competition now that Zyprexa has lost exclusivity in the US and EU. Zyprexa sales are expected to erode significantly in 2012. The generic ...

Many Primary Care Docs Don't Know Long-Term Effects of Chemo: Survey - YAHOO!

A second study being presented at the ASCO meeting in June found that the antipsychotic drug Zyprexa (olanzapine), used to treat schizophrenia and bipolar disorder, reduced post-chemotherapy nausea and vomiting among patients who had not responded to other therapies.

Dr. Reddy's Launches Plavix' Generic - Analyst Blog - NASDAQ

Last month Dr. Reddy's launched the generic version of Teva Pharmaceutical Industries Ltd. 's ( TEVA) antipsychotic drug, Zyprexa in the U.S. The generic drug was awarded 180-day marketing exclusivity in the U.S. on October 26, 2011, following a ...

4 Big Pharma Stocks To Nab In A Pullback - Seekingalpha.com

As stated earlier, Lilly's U.S. patent on Zyprexa expired October 23rd, 2011. On October 21st, 2011, the stock closed at $37.11. Lilly's share price has risen some 11% since the patent expired. In fact, Lilly beat consensus earnings estimates in its first ...

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Bristol-Myers Squibb, Teva Pharmaceutical, Biogen Idec and Elan - Press Releases - NASDAQ

Last month Dr. Reddy's launched the generic version of Teva Pharmaceutical Industries Ltd. 's ( TEVA) antipsychotic drug, Zyprexa in the U.S. The generic drug was awarded 180-day marketing exclusivity in the U.S. on October 26, 2011, following a ...

Drug makers shifting towards targeted cancer drugs - Marketwatch

The antipsychotic olanzapine was tested as an agent to relieve nausea and vomiting associated with cancer chemotherapy. Eli Lilly & Co. (NYSE:LLY) markets the drug as Zyprexa, but generic versions are available from multiple manufacturers.